Fluoxetine
FLUOXETINE, Prozac
Serotonin Reuptake Inhibitor
NADAC/unit
$0.0298
No Shortage
Tier 1: 335.3%
24 Manufacturers
67 ANDAs
Fluoxetine is indicated for the treatment of: Acute and maintenance treatment of Major Depressive Disorder [see Clinical Studies (14.1) ] .
vs. brand FLUOXETINE: Generic saves up to 100% per unit
Market Intelligence
2025-06-11 Class II Recall: Torrent Pharma Inc.
2025-06-11 Class II Recall: Torrent Pharma Inc.
Generic Manufacturers
ALEMBIC PHARMACEUTICALS LTDAUROBINDO PHARMA LTDCADILA PHARMACEUTICALS LTDDR REDDYS LABORATORIES LTDELI LILLY AND COHERITAGE PHARMACEUTICALS INC DBA AVET PHARMACEUTICALS INCINVENTIA HEALTHCARE PRIVATE LTDIVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USALANDELA PHARMACEUTICALLANNETT CO INCLUPIN LTDMARKSANS PHARMA LTDMICRO LABS LTDNOVITIUM PHARMA LLCPH HEALTH LTDPHARMACEUTICAL ASSOCIATES INCSCIEGEN PHARMACEUTICALS INCSENORES PHARMACEUTICALS INCSOLIS PHARMACEUTICALS INCSOMERSET THERAPEUTICS LLCSTRIDES PHARMA GLOBAL PTE LTDTEVA PHARMACEUTICALS USATEVA PHARMACEUTICALS USA INCTORRENT PHARMACEUTICALS LTDUPSHER SMITH LABORATORIES LLC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.